Deuterium Metabolic Imaging to measure hepatic fructose metabolism


Published June 30, 2025

Chronic intake of high amounts of fructose has been linked to the development of metabolic disorders caused by the almost complete clearance of fructose by the liver. However, direct measurement of hepatic fructose uptake is complicated by the fact that the portal vein is difficult to access. 

Dr. Arjan Hendriks, from the University Medical Center Utrecht, applied for access at the PRIME Node to explore the opportunities and potential effectiveness of different deuterated compounds to map body metabolism with deuterium metabolic imaging (DMI), and thanks to the data obtained during this access he developed a new, non-invasive method to measure hepatic fructose uptake and metabolism, based on administration of [6,6’-2H2]fructose followed by DMI. 

issue concentration of deuterated glucose and/or fructose
Tissue concentration of deuterated glucose and/or fructose, and of deuterated water as a function of time during and after a bolus injection versus a slow IV infusion of [6,6’-2H2]glucose and [6,6’-2H2]fructose. Figures have been adapted from: https://doi.org/10.3389/fphys.2023.1198578 Used under a Creative Commons CC-BY 4.0 license.

The application of this method in mice showed a higher extraction and faster turnover of fructose in the liver, as compared with glucose. Furthermore, comparing high concentration bolus injections with a slow low concentration infusion gave more insight into the fructose build up in the liver as compared to glucose. DMI with [6,6’-2H2]glucose and [6,6’-2H2]fructose could potentially contribute to a better understanding of healthy human liver metabolism and aberrations in metabolic diseases.

In vivo anatomical 3D MR images
In vivo anatomical 3D MR images were acquired as a guide to perform B0 shimming on a voxel (orange) and to position the DMI grid (green). Figures have been adapted from: https://doi.org/10.3389/fphys.2023.1198578. Used under a Creative Commons CC-BY 4.0 license.

This is an example of research that can be supported by the Euro-BioImaging’s PRIME Node.

About Euro-BioImaging’s PRIME Node

The Dutch Preclinical Imaging Center PRIME – Molecular Imaging Node is a dual-sited Node that consists of the Preclinical Imaging Centre (PRIME), Radboud University Nijmegen, and the Intravital Microscopy Facility (IMF), Hubrecht Institute, Utrecht. This Node is a centralized facility for multimodality imaging of small animals, such as mice and rats. PRIME is the only centre in the Netherlands where more than four imaging modalities for small animal imaging are housed under one roof in one facility. The intravital microscopy laboratory offers advanced genetic mouse models and has heavily invested in state-of-the-art imaging of small animals using multiphoton microscopy. PRIME functions as single-site facility for small animal imaging with state-of-the-art equipment and expertise for magnetic resonance imaging (MRI), positron emission tomography (PET/CT), single photon emission computed tomography (SPECT/CT), intravital multi-photon fluorescence imaging (MPFI) and high frequency ultrasound imaging (HFUS).


More news from Euro-BioImaging

November 6, 2025

Inspiring Scientists Across Borders: A Transformative Experience Through the EVOLVE Mentoring and Job Shadowing Program

The EVOLVE project continues to showcase how structured mentoring and immersive job shadowing can empower researchers to learn, connect, and share expertise across borders,…

Train the Trainer course 2025 group photo

November 5, 2025

Euro-BioImaging Train-the-Trainer 2025: Empowering trainers across Europe

From the 20th to the 24th of October the Euro-BioImaging team had the immense pleasure of welcoming more than 30 colleagues from 20 Nodes…

EOSC Federation

November 5, 2025

EOSC Federation: MoU establishes shared path to operations

BRUSSELS—At the EOSC Symposium, the European Open Science Cloud (EOSC) took a major step toward its consolidation as Europe’s research and innovation data space.